Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) traded down 24.2% during mid-day trading on Monday . The company traded as low as $0.19 and last traded at $0.23. 4,676 shares traded hands during trading, an increase of 5% from the average session volume of 4,454 shares. The stock had previously closed at $0.30.
Viva Biotech Price Performance
The company’s fifty day moving average price is $0.22 and its two-hundred day moving average price is $0.15.
About Viva Biotech
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions.
Read More
- Five stocks we like better than Viva Biotech
- Insider Buying Explained: What Investors Need to Know
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- How to trade penny stocks: A step-by-step guide
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- How to Profit From Growth Investing
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
